Physician
Pathology
Dr. Thomas M. Daly, MD
|
|
Give Review
Thomas M. Daly practices Pathology. He attended Washington University School of Medicine in St. Louis. Thomas Daly is a published physician. He has 64 publications published. The most current publication "Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge." Doctor Thomas M. Daly, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- Synovial fluid interleukin-6 as a predictor of periprosthetic shoulder infection.
- Use and Clinical Interpretation of Pneumococcal Antibody Measurements in the Evaluation of Humoral Immune Function.
- Multilaboratory Assessment of Threshold versus Fold-Change Algorithms for Minimizing Analytical Variability in Multiplexed Pneumococcal IgG Measurements.
- Evaluation of commercially available reagents for the diagnosis of Histoplasmosis infection in immunocompromised patients.
- Impact of analytical variability on clinical interpretation of multiplex pneumococcal serology assays.
- Analytical and biological validation of a multiplex immunoassay for acute kidney injury biomarkers.
- Identifying false-positive syphilis antibody results using a semi-quantitative algorithm.
- Elevated levels of the Plasmodium yoelii homologue of macrophage migration inhibitory factor attenuate blood-stage malaria.
- Distinct malaria parasite sporozoites reveal transcriptional changes that cause differential tissue infection competence in the mosquito vector and mammalian host.
- High mobility group protein HMGB2 is a critical regulator of plasmodium oocyst development.
- Functional characterization of a redundant Plasmodium TRAP family invasin, TRAP-like protein, by aldolase binding and a genetic complementation test.
- A combined transcriptome and proteome survey of malaria parasite liver stages.
- Multiplex assay for comprehensive genotyping of genes involved in drug metabolism, excretion, and transport.
- Structure of the MTIP-MyoA complex, a key component of the malaria parasite invasion motor.
- Alteration in host cell tropism limits the efficacy of immunization with a surface protein of malaria merozoites.
- Precision profiling and components of variability analysis for Affymetrix microarray assays run in a clinical context.
- Regulation by phosphorylation of Pho81p, a cyclin-dependent kinase inhibitor in Saccharomyces cerevisiae.
- Pathologic quiz case: repeated positive ethylene glycol levels by gas chromatography. Central venous line contamination of blood samples by propylene glycol from intra...
- A co-ligand complex anchors Plasmodium falciparum merozoites to the erythrocyte invasion receptor band 3.
- Members of the merozoite surface protein 7 family with similar expression patterns differ in ability to protect against Plasmodium yoelii malaria.
- Overestimation of HDL-cholesterol using a homogeneous "direct" assay.
- Overview of adeno-associated viral vectors.
- AAV-mediated gene transfer to the liver.
- Utilization, reliability, and clinical impact of point-of-care testing during critical care transport: six years of experience.
- Polydrug fatality involving metaxalone.
- A multigene family that interacts with the amino terminus of plasmodium MSP-1 identified using the yeast two-hybrid system.
- Adeno-associated virus-mediated gene transfer to the neonatal brain.
- Evaluation of a no-pretreatment cyclosporin A assay on the Dade Behring dimension RxL clinical chemistry analyzer.
- Comparison of non-diglyceride- and diglyceride-based assays for pancreatic lipase activity.
- Pyrazoleamide compounds are potent antimalarials that target Na(+) homeostasis in intraerythrocytic Plasmodium falciparum.
- Cholesterol supplementation prevents necrosis and inflammation but enhances fibrosis in alcoholic liver disease in the rat.
- Observation of lymphatic vessels in orbital fat of patients with inflammatory conditions: a form fruste of lymphangiogenesis?
- Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alfa and reverse fibrosis in alcohol-induced liver disease in the rat.
- Abnormal immune function in vivo in a murine model of lysosomal storage disease.
- Gene therapy for lysosomal storage diseases.
- "Bouncing" creatinine levels.
- Analysis and variability of TGFbeta measurements in cancer patients with skeletal metastases.
- Novel polymorphism in the FMR1 gene resulting in a "pseudodeletion" of FMR1 in a commonly used fragile X assay.
- Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors.
- Increased functional expression of transgene in primary human lymphocytes using retroviral vectors modified with IRES and splicing motifs.
- CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and...
- Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII.
- Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged beta-glucuronidase expression in situ and correction of liver pathology i...
- Mechanisms of dopamine and dobutamine interference in biochemical tests that use peroxide and peroxidase to generate chromophore.
- Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer.
- Protective efficacy against malaria of a combination sporozoite and erythrocytic stage vaccine.
- Development and validation of a phosphorylated SMAD ex vivo stimulation assay.
- Immunity to erythrocytic stages of malarial parasites.
- Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease.
- Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection.
- Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria.
- Plasmodium yoelii: the role of the individual epidermal growth factor-like domains of the merozoite surface protein-1 in protection from malaria.
- Structure-based design of novel small-molecule inhibitors of Plasmodium falciparum.
- Interaction between two domains of the P. yoelii MSP-1 protein detected using the yeast two-hybrid system.
- Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
- Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite.
- Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model.
- Both epidermal growth factor-like domains of the merozoite surface protein-1 from Plasmodium yoelii are required for protection from malaria.
- Comparison of the carboxy-terminal, cysteine-rich domain of the merozoite surface protein-1 from several strains of Plasmodium yoelii.
- A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice.
- Myosin A tail domain interacting protein (MTIP) localizes to the inner membrane complex of Plasmodium sporozoites.
- Comprehensive assessment of metabolic enzyme and transporter genes using the Affymetrix Targeted Genotyping System.
- The closed MTIP-myosin A-tail complex from the malaria parasite invasion machinery.
Schools
Washington Center School of Medicine
Doctors Specialties
- Pathology
Accepted Insurances
Education
-
Washington University -
Washington University School of Medicine in St. Louis
Hospital
-
Cleveland Clinic
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1851546949 |
| Last Name Of The Provider | DALY |
| First Name Of The Provider | THOMAS |
| View All |
Similar Doctors
|
|
Dr. Khaled Sarah, MD |